Bio-Path (BPTH) Short Interest Ratio & Short Volume $0.82 +0.01 (+0.74%) As of 01/17/2025 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Bio-Path Short Interest DataBio-Path (BPTH) has a short interest of 250,000 shares, representing 5.80% of the float (the number of shares available for trading by the public). This marks a 189.35% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 6.24 million shares to cover all short positions.Current Short Interest250,000 sharesPrevious Short Interest86,400 sharesChange Vs. Previous Month+189.35%Dollar Volume Sold Short$290,000.00Short Interest Ratio0.1 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares4,307,000 sharesFloat Size4,310,000 sharesShort Percent of Float5.80%Today's Trading Volume106,243 sharesAverage Trading Volume6,237,951 sharesToday's Volume Vs. Average2% Short Selling Bio-Path? Sign up to receive the latest short interest report for Bio-Path and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBPTH Short Interest Over TimeBPTH Days to Cover Over TimeBPTH Percentage of Float Shorted Over Time Bio-Path Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/2024250,000 shares $290,000.00 +189.4%5.8%0.1 $1.16 12/15/202486,400 shares $57,127.68 +179.6%2.0%0 $0.66 11/30/202430,900 shares $23,793.00 -18.9%0.7%0 $0.77 11/15/202438,100 shares $30,956.25 -51.0%0.9%0 $0.81 10/31/202477,800 shares $70,447.90 -80.0%2.1%0.1 $0.91 10/15/2024388,600 shares $446,890.00 +3,947.9%10.5%0.3 $1.15 9/30/20249,600 shares $8,735.04 -41.5%0.4%0 $0.91 9/15/202416,400 shares $16,728.00 -64.4%0.6%0 $1.02 8/31/202446,100 shares $45,484.52 -16.6%1.8%0.1 $0.99 8/15/202455,300 shares $82,397.00 -9.6%2.2%0 $1.49 Get the Latest News and Ratings for BPTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bio-Path and its competitors with MarketBeat's FREE daily newsletter. 7/31/202461,200 shares $96,696.00 -45.0%2.9%0.1 $1.58 7/15/2024111,300 shares $213,696.00 -23.5%5.4%0.1 $1.92 6/30/2024145,400 shares $290,800.00 +76.0%7.0%0.1 $2.00 6/15/202482,600 shares $178,416.00 +159.8%4.0%0 $2.16 5/31/202431,800 shares $65,508.00 +32.5%2.0%0 $2.06 5/15/202424,000 shares $53,760.00 -46.0%1.5%0 $2.24 4/30/202444,400 shares $125,652.00 +62.0%2.9%0 $2.83 4/15/202427,400 shares $80,830.00 -59.4%3.6%0 $2.95 3/31/202467,400 shares $277,688.00 +6.3%9.0%2.7 $4.12 3/15/202463,400 shares $291,640.00 +284.2%9.6%3 $4.60 2/29/202416,500 shares $100,320.00 -14.5%2.7%1.7 $6.08 2/15/202419,300 shares $170,612.00 -94.9%3.1%2.9 $8.84 1/31/2024378,300 shares $162,669.00 -6.0%N/A3.5 $0.43 1/15/2024402,500 shares $201,250.00 +7.3%N/A1.7 $0.50 12/31/2023375,200 shares $173,717.60 -12.9%N/A0.1 $0.46 12/15/2023430,900 shares $202,523.00 -18.6%N/A0.2 $0.47 11/30/2023529,600 shares $296,576.00 -23.9%N/A0.2 $0.56 11/15/2023695,700 shares $371,225.52 -28.3%N/A0.3 $0.53 10/31/2023969,600 shares $639,451.20 +240.3%N/A0.4 $0.66 10/15/2023284,900 shares $213,675.00 +66.9%N/A0.1 $0.75 9/30/2023170,700 shares $63,159.00 -21.2%N/A0.5 $0.37 9/15/2023216,700 shares $88,847.00 +23.1%N/A0.6 $0.41 8/31/2023176,000 shares $72,652.80 -19.4%N/A0.5 $0.41 8/15/2023218,300 shares $82,735.70 -46.7%N/A0.7 $0.38 7/31/2023409,300 shares $433,858.00 +44.1%N/A1.4 $1.06 7/15/2023284,000 shares $369,200.00 +44.8%N/A6.9 $1.30 6/30/2023196,200 shares $349,236.00 +111.9%N/A5.8 $1.78 6/15/202392,600 shares $152,780.74 +15.3%N/A2.8 $1.65 5/31/202380,300 shares $132,495.00 +7.5%N/A3 $1.65 5/15/202374,700 shares $112,050.00 +6.1%N/A2.5 $1.50Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know. 4/30/202370,400 shares $99,264.00 -15.8%N/A2.3 $1.41 4/15/202383,600 shares $116,195.64 +10.0%N/A2.4 $1.39 3/31/202376,000 shares $105,640.00 +18.6%N/A2.1 $1.39 3/15/202364,100 shares $96,150.00 -9.7%N/A1.7 $1.50 2/28/202371,000 shares $128,510.00 +59.2%N/A1.8 $1.81 2/15/202344,600 shares $88,018.10 +49.7%N/A1.1 $1.97 1/31/202329,800 shares $61,984.00 +122.4%N/A0.4 $2.08 1/15/202313,400 shares $23,986.00 -53.2%N/A0.2 $1.79 12/30/202228,600 shares $43,186.00 -21.6%N/A0.5 $1.51 12/15/202236,500 shares $54,385.00 +644.9%N/A0.6 $1.49 11/30/20224,900 shares $7,203.00 -84.9%N/A0.1 $1.47 11/15/202232,500 shares $49,725.00 -5.3%N/A0.6 $1.53 10/31/202234,300 shares $111,475.00 +0.3%2.0%0.8 $3.25 10/15/202234,200 shares $110,466.00 -0.9%2.0%2 $3.23 9/30/202234,500 shares $110,055.00 -7.0%2.0%1.7 $3.19 9/15/202237,100 shares $139,867.00 -13.3%2.2%1.3 $3.77 8/31/202242,800 shares $156,648.00 -11.0%2.5%1.4 $3.66 8/15/202248,100 shares $198,653.00 -7.5%2.8%1.4 $4.13 7/31/202252,000 shares $185,120.00 -2.1%3.0%1.4 $3.56 7/15/202253,100 shares $221,427.00 -13.4%3.1%1.3 $4.17 6/30/202261,300 shares $237,231.00 -31.1%3.6%0.9 $3.87 6/15/202288,900 shares $321,818.00 +8.2%5.2%1.3 $3.62 5/31/202282,200 shares $293,454.00 -17.8%N/A1.2 $3.57 5/15/2022100,000 shares $304,000.00 +47.9%N/A1.5 $3.04 4/30/202267,600 shares $198,068.00 -29.7%N/A1.1 $2.93 4/15/202296,200 shares $290,524.00 +60.1%N/A1.5 $3.02 3/31/202260,100 shares $230,784.00 -31.9%N/A1.7 $3.84 3/15/202288,300 shares $264,017.00 -19.7%N/A1.9 $2.99 2/28/2022110,000 shares $412,500.00 -0.5%N/A1.8 $3.75 2/15/2022110,600 shares $436,870.00 -16.5%N/A1.3 $3.95 1/31/2022132,400 shares $450,160.00 +7.3%N/A1.5 $3.40 1/15/2022123,400 shares $486,751.30 -15.2%N/A1.2 $3.94 12/31/2021145,500 shares $548,535.00 -15.3%N/A1.5 $3.77 12/15/2021171,800 shares $723,278.00 +100.9%N/A1.8 $4.21 11/30/202185,500 shares $378,765.00 -38.4%N/A0.9 $4.43 11/15/2021138,900 shares $647,274.00 +6.4%N/A0.1 $4.66 10/29/2021130,600 shares $619,044.00 +96.7%N/A0.1 $4.74 10/15/202166,400 shares $343,288.00 +14.5%1.0%0.1 $5.17 9/30/202158,000 shares $297,540.00 -11.0%0.8%0.1 $5.13 9/15/202165,200 shares $339,040.00 -70.5%0.9%0.1 $5.20 8/31/2021221,300 shares $1.26 million +138.5%3.2%0.2 $5.68 8/13/202192,800 shares $604,128.00 -20.1%1.3%0.5 $6.51 7/30/2021116,100 shares $743,040.00 -19.5%1.7%0.6 $6.40 7/15/2021144,300 shares $903,318.00 -28.5%2.1%0.6 $6.26 6/30/2021201,800 shares $1.35 million -15.3%2.9%0.8 $6.67 6/15/2021238,300 shares $1.53 million -12.6%3.5%0.4 $6.43 5/28/2021272,600 shares $1.55 million -0.6%4.0%0.5 $5.70 5/14/2021274,200 shares $1.41 million +20.6%N/A0.4 $5.13 4/30/2021227,300 shares $1.39 million -2.5%N/A0.1 $6.10 4/15/2021233,100 shares $1.44 million +208.7%N/A0.1 $6.17Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know. 3/31/202175,500 shares $518,685.00 -39.7%N/A0 $6.87 3/15/2021125,100 shares $935,748.00 +11.9%N/A0.1 $7.48 2/26/2021111,800 shares $722,228.00 -76.4%N/A0.1 $6.46 2/12/2021474,200 shares $4.50 million +88.6%N/A0.2 $9.50 1/29/2021251,400 shares $1.03 million +3.5%N/A0.9 $4.08 1/15/2021242,900 shares $981,316.00 -3.9%N/A0.8 $4.04 12/31/2020252,800 shares $920,192.00 -5.4%N/A0.2 $3.64 12/15/2020267,200 shares $999,328.00 +10.5%N/A0.3 $3.74 11/30/2020241,800 shares $846,300.00 +6.9%N/A0.2 $3.50 11/15/2020226,100 shares $757,435.00 +92.4%N/A0.2 $3.35 10/30/2020117,500 shares $399,500.00 +2,117.0%N/A0.1 $3.40 10/15/20205,300 shares $22,154.00 -50.9%N/A0 $4.18 9/30/202010,800 shares $45,792.00 -76.9%N/A0.1 $4.24 9/15/202046,800 shares $203,580.00 -16.6%N/A0.3 $4.35 8/31/202056,100 shares $241,230.00 +516.5%N/A0.3 $4.30 8/14/20209,100 shares $45,045.00 +11.0%N/A0.1 $4.95 7/31/20208,200 shares $41,574.00 -16.3%N/A0.1 $5.07 7/15/20209,800 shares $48,412.00 -36.0%N/A0.1 $4.94 6/30/202015,300 shares $78,336.00 +62.8%N/A0.2 $5.12 6/15/20209,400 shares $49,256.00 No ChangeN/A0.1 $5.24 5/29/20209,400 shares $51,982.00 -49.7%N/A0.1 $5.53 5/15/202018,700 shares $89,386.00 +65.5%N/A0.2 $4.78 4/30/202011,300 shares $58,308.00 -41.2%N/A0.1 $5.16 4/15/202019,200 shares $111,168.00 -59.2%N/A0.2 $5.79 3/31/202047,000 shares $269,310.00 -18.0%N/A0.4 $5.73 3/13/202057,300 shares $268,737.00 -5.8%2.1%0.5 $4.69 2/28/202060,800 shares $207,328.00 +15.6%2.3%0.6 $3.41 2/14/202052,600 shares $278,254.00 +18.7%2.0%0.3 $5.29 1/31/202044,300 shares $256,054.00 -66.5%1.7%0.3 $5.78 BPTH Short Interest - Frequently Asked Questions What is Bio-Path's current short interest? Short interest is the volume of Bio-Path shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 250,000 shares of BPTH short. 5.80% of Bio-Path's shares are currently sold short. Learn More on Bio-Path's current short interest. What is a good short interest percentage for Bio-Path? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.80% of Bio-Path's floating shares are currently sold short. Is Bio-Path's short interest increasing or decreasing? Bio-Path saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 250,000 shares, an increase of 189.4% from the previous total of 86,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bio-Path's float size? Bio-Path currently has issued a total of 4,307,000 shares. Some of Bio-Path's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bio-Path currently has a public float of 4,310,000 shares. How does Bio-Path's short interest compare to its competitors? 5.80% of Bio-Path's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Bio-Path: Cingulate Inc. (3.67%), Spruce Biosciences, Inc. (0.26%), NeuroSense Therapeutics Ltd. (1.48%), HCW Biologics Inc. (0.66%), Bright Green Co. (0.89%), Imunon, Inc. (7.04%), Hoth Therapeutics, Inc. (9.26%), CervoMed Inc. (23.55%), Flora Growth Corp. (7.61%), Sensei Biotherapeutics, Inc. (0.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Bio-Path stock? Short selling BPTH is an investing strategy that aims to generate trading profit from Bio-Path as its price is falling. BPTH shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bio-Path? A short squeeze for Bio-Path occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BPTH, which in turn drives the price of the stock up even further. How often is Bio-Path's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BPTH, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies CING Short Squeeze SPRB Short Squeeze NRSN Short Squeeze HCWB Short Squeeze BGXX Short Squeeze IMNN Short Squeeze HOTH Short Squeeze CRVO Short Squeeze FLGC Short Squeeze SNSE Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BPTH) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Path Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Path With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BPTH Stock Alerts